Company profile
Windtree Therapeutics, Inc.
OTC: WINT · Healthcare · Biotechnology
PublicHQ Warrington, PACIK 0000946486Reports USD
#1003 of 1,418 Healthcare companies by revenue70th-percentile growth
EA Score
——FH —DQ 28GM —SS 45
v0.1 · 25/100 weight · pillars only
↑ listing tenure, return on assets · ↓ operating margin, market scale
Methodology →Revenue TTM
$90.0k
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$1.8M
Employees
14
as of 2026-08-26
Market cap
$3.4k
as of 2026-08-26
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$198.0k$198.0k2020
Net income-$1.8M-$1.8M2024
Operating income-$26.1M-$26.1M2024
Total assets$27.9M$27.9M2024
Liabilities$14.7M$14.7M2024
Equity$10.0M$10.0M2024
Revenue trend
FY2018 – FY2020 · USD
FY18
FY18
FY18
FY18
FY18
FY19
FY19
FY20
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Windtree Therapeutics, Inc.’s revenue?
Windtree Therapeutics, Inc. booked $198.0k in FY2020 revenue, growing 25% year over year — faster than most Healthcare companies we track, at a -902.5% net margin.
Peers · Healthcare
Sharps Technology, Inc.33DLixte Biotechnology Holdings, Inc.40DClene Inc.27DCardioComm Solutions, Inc.25DBioxytran, Inc.27DaTyr Pharma, Inc.36DKey facts
CEOJed A. Latkin
SectorHealthcare
IndustryBiotechnology
HeadquartersWarrington, PA
ExchangeOTC: WINT
Employees14
IPO date1995-08-07
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.